Icodextrin Peritoneal Dialysis Solution + Hypertonic Dextrose solution

ApprovedRecruiting
0 watching 0 views this week๐Ÿ”ฅ Hot
82
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

Peritoneal Dialysis

Conditions

Peritoneal Dialysis

Trial Timeline

May 24, 2023 โ†’ Dec 31, 2025

About Icodextrin Peritoneal Dialysis Solution + Hypertonic Dextrose solution

Icodextrin Peritoneal Dialysis Solution + Hypertonic Dextrose solution is a approved stage product being developed by Baxter for Peritoneal Dialysis. The current trial status is recruiting. This product is registered under clinical trial identifier NCT05721404. Target conditions include Peritoneal Dialysis.

Hype Score Breakdown

Clinical
30
Activity
20
Company
7
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT05721404ApprovedRecruiting

Competing Products

20 competing products in Peritoneal Dialysis

See all competitors
ProductCompanyStageHype Score
azenosertibZentalis PharmaceuticalsPhase 2
44
MCY-M11 + CyclophosphamideMaxCytePhase 1
25
R744 + R744Chugai PharmaceuticalPhase 3
77
roxadustatAstellas PharmaPhase 3
77
AbemaciclibEli LillyPhase 1
33
M200 (Volociximab) + Liposomal Doxorubicin + M200 (Volociximab) + M200 (Volociximab)AbbViePhase 1/2
41
Adavosertib + Paclitaxel + Carboplatin + Gemcitabine + PLDAstraZenecaPhase 2
52
Tremelimumab + OlaparibAstraZenecaPhase 1
33
ertapenemMerckApproved
85
Octreotide LAR + Octreotide (Immediate release) + methylprednisolone + PlaceboNovartisPhase 2
52
PA21Kissei PharmaceuticalPhase 3
76
PF-06873600 + Endocrine Therapy 1 + Endocrine Therapy 2PfizerPhase 1/2
40
Bevacizumab + Nivolumab + RucaparibBristol Myers SquibbPhase 2
51
IniparibSanofiPhase 2
51
Sevelamer Hydrochloride (Renagelยฎ) + Calcium acetate (PhosLoยฎ )SanofiPhase 3
76
nanoliposomal irinotecanIpsenPhase 1
30
Extraneal (7.5% icodextrin) Peritoneal Dialysis SolutionBaxterApproved
82
Anti-Adhesion ProductBaxterPhase 2
49
PioglitazoneBaxterPre-clinical
20
RadspherinOncoinventPhase 2
44